UBS Oncology Impact Fund L.P. - Insider Non-Derivative Transactions at TCR2 THERAPEUTICS INC. (TCRR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 1, 2023, UBS Oncology Impact Fund L.P.'s relationship to TCR2 THERAPEUTICS INC. (TCRR) is TenPercentOwner, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TCRR insiders.
Data Source: SEC.
UBS Oncology Impact Fund L.P. - Insider Non-Derivative Transactions at TCRR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 2, 2023 | J -- (Common Stock) | 3370982 | 0 | 0 |